Revance Therapeutics Inc
Company Profile
Business description
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
Contact
1222 Demonbreun Street
Suite 2000
Nashville TN 37203
USAT: +1 615 724-7755
E: jherbert@revance.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
597
Stocks News & Analysis
video
Now the dust has settled, a mini earnings wrap
stocks
This moated ASX stock is swimming in cash
video
ASX shares to own forever
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,323.50 | 30.40 | 0.37% |
| CAC 40 | 7,435.07 | 38.24 | 0.52% |
| DAX 40 | 18,518.39 | 188.12 | 1.03% |
| Dow JONES (US) | 41,096.77 | 235.06 | 0.58% |
| FTSE 100 | 8,240.97 | 47.03 | 0.57% |
| HKSE | 17,375.18 | 134.79 | 0.78% |
| NASDAQ | 17,569.68 | 174.14 | 1.00% |
| Nikkei 225 | 36,581.76 | 251.51 | -0.68% |
| NZX 50 Index | 12,832.55 | 12.27 | 0.10% |
| S&P 500 | 5,595.76 | 41.63 | 0.75% |
| S&P/ASX 200 | 8,099.90 | 24.20 | 0.30% |
| SSE Composite Index | 2,707.92 | 9.20 | -0.34% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Red 5 Ltd RED | 0.33 | 0.03 | 8.20% |
| Latin Resources Ltd LRS | 0.20 | 0.01 | 2.56% |
| Pilbara Minerals Ltd PLS | 2.90 | 0.02 | 0.69% |
| Bowen Coking Coal Ltd BCB | 0.01 | 0.00 | 0.00% |
| Telstra Group Ltd TLS | 3.96 | 0.00 | 0.00% |
| Imugene Ltd IMU | 0.05 | 0.00 | 0.00% |
| Appen Ltd APX | 1.55 | 0.05 | 3.33% |
| South32 Ltd S32 | 3.19 | 0.11 | 3.57% |
| Fortescue Ltd FMG | 17.50 | 0.84 | 5.04% |
| Resolute Mining Ltd RSG | 0.74 | 0.04 | 5.76% |